# Guangzhou Burning Rock Medical Examination Institute Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangzhou-burning-rock-medical-examination-institute-co

- Industry: Pharmaceuticals
- Headquarters: Guangzhou, China
- Website: www.brbiotech.com
- Total disclosed funding: $202M
- Latest round: Series C (Feb 14, 2019)
- Investors on record: 8

## About

Founded in 2014 and based in Guangzhou, China, Guangzhou Burning Rock Medical Examination Institute Co., Ltd. is a cancer treatment research and development firm. The firm primarily engages in next generation sequencing and clinical treatment.

## Funding rounds

- Series C, Feb 14, 2019, $126M — Hong Shan, Lilly Asia Ventures, CMB International Asset Management, LYFE Capital, Taihe Capital, GIC
- Series B, Dec 29, 2016, $43M — Hong Shan, CMB International Asset Management, Legend Star, LYFE Capital
- Series A, Aug 17, 2015, $23M — Hong Shan, Legend Star, LYFE Capital
- Series A, Jun 1, 2014, $10M — NLVC, Legend Star

## Investors

- NLVC (https://capitalatlas.ai/funds/nlvc) — Series A
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A, Series B
- Hong Shan — Series A, Series B, Series C
- LYFE Capital — Series A, Series B, Series C
- CMB International Asset Management (https://capitalatlas.ai/funds/cmb-international-asset-management) — Series B, Series C
- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series C
- Taihe Capital — Series C
- GIC — Series C